NEW
Stock Screener with Intrinsic Value
United Therapeutics Corporation (UTHR)
Last Price$365.0(0.4%)
Market Cap$16.2B
70.4%
Industry median - (125.1%)
5Y Historical average - 55.7%
63.5%
Industry median - (131.8%)
5Y Historical average - 50.2%
18.8%
Industry median - (52.2%)
5Y Historical average - 14.6%
15.7%
Industry median - (51.2%)
5Y Historical average - 11.5%
UTHR Capital Allocation Rating
Crunching data... Almost there!
UTHR Capital Allocation metrics
Crunching data... Almost there!
Competing with UTHR Capital Allocation
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the United Therapeutics Corporation (UTHR) ROIC (Return on Invested Capital)?
The United Therapeutics Corporation (UTHR) ROIC is 70.4%, compared to the industry median of ((125.1%)) and the 5-year historical average of 55.7%.
What is the United Therapeutics Corporation (UTHR) ROIC minus WACC (Weighted Average Cost of Capital)?
The United Therapeutics Corporation (UTHR) ROIC minus WACC is 63.5%, compared to the industry median of ((131.8%)) and the 5-year historical average of 50.2%.
What is the United Therapeutics Corporation (UTHR) ROE (Return on Equity)?
The United Therapeutics Corporation (UTHR) ROE is 18.8%, compared to the industry median of ((52.2%)) and the 5-year historical average of 14.6%.
What is the United Therapeutics Corporation (UTHR) ROCE (Return on Capital Employed)?
The United Therapeutics Corporation (UTHR) ROCE is 15.7%, compared to the industry median of ((51.2%)) and the 5-year historical average of 11.5%.